A large, multinational drug corporation conducts a phase I clinical trial to evaluate the safety profile and pharmacokinetic properties of a new drug designed to treat refractory epilepsy. Initial studies in animals showed that the drug undergoes extensive metabolism by the liver into glucuronidation byproducts that are primarily excreted by the kidneys. The curve below demonstrates the glucuronidation rate of the drug over a wide range of doses.
Which of the following is the most accurate statement about this drug's metabolism?
A) A constant proportion of the drug is metabolized past point 3
B) Bioavailability of the drug is highest at point 1
C) Biotransformation of the drug ceases near point 2
D) Metabolism begins to switch to zero-order kinetics near point 2
E) The rate of drug metabolism is not dependent on dose before point 1
Correct Answer:
Verified
Q204: A 55-year-old woman comes to the physician
Q205: A 60-year-old man with chronic atrial fibrillation
Q206: Researchers create a cohort of experimental rats
Q207: A 42-year-old woman comes to the office
Q208: The office receives a follow-up visit from
Q210: A 13-year-old girl is brought to the
Q211: A 76-year-old woman is taken to the
Q212: Researchers looked at how various muscarinic agonists
Q213: A 77-year-old man is brought to the
Q214: A 64-year-old man visits the office after
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents